The Group's principal activities are researching, developing, manufacturing and distributing pharmaceutical products in the People's Republic of China. The Group currently manufactures four types of biopharmaceutical products, making use of technical know-how injected by the former majority shareholder of Shenyang Sunshine and the Group's own research and development.
Alacra Alerts:
Receive alerts on the latest reports on 3SBio Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
